News

Perioperative MRI fails to reduce recurrence risk in women with ductal carcinoma in situ

Publish date: September 5, 2013

 

FROM THE ASCO BREAST CANCER SYMPOSIUM

Overall, 26% of the patients studied had breast MRI near the time of surgery, most commonly preoperatively, to assess disease extent.

Dr. Pilewskie and Dr. O’Day disclosed no relevant conflicts of interest.

Pages

Recommended Reading

Age does not impact survival in HER2-positive breast cancer
MDedge Hematology and Oncology
Long-term CCB therapy linked to higher breast cancer risk
MDedge Hematology and Oncology
Bernard Fisher at 95
MDedge Hematology and Oncology
Lymph node status predicted 10-year mortality in BRCA1 mutation carriers with small, stage I-III breast cancers
MDedge Hematology and Oncology
Long-term amenorrhea risk no higher for premenopausal breast cancer patients with BRCA mutations
MDedge Hematology and Oncology
Adjuvant ibandronate adds no benefit in early stage, node-positive breast cancer
MDedge Hematology and Oncology
Occult cancer: suspected breast and BRCA gene mutations
MDedge Hematology and Oncology
Minimizing cancer’s impact on bone with denosumab: current and future perspectives
MDedge Hematology and Oncology
No increase in cardiovascular risk seen after radiation therapy for DCIS
MDedge Hematology and Oncology
Most women misestimate their breast cancer risk
MDedge Hematology and Oncology